Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation

Authors: Nozzoli, Chiara ^{1, ⁎}, Pucillo, Martina ², Giaccone, Luisa ³, Rambaldi, Alessandro ⁴, Stanghellini, Maria Teresa Lupo ⁵, Benedetti, Edoardo ⁶, Russo, Domenico ⁷, Mordini, Nicola ⁸, Mangiacavalli, Silvia ⁹, Bernasconi, Paolo ⁹, Parma, Matteo ¹⁰, Carluccio, Paola ¹¹, Galieni, Piero ¹², Rivela, Paolo ¹³, Martino, Massimo ¹⁴, Chiusolo, Patrizia ¹⁵, Isola, Miriam ¹⁶, De Martino, Maria ¹⁶, Oldani, Elena ⁴, Degrandi, Eliana ¹⁷, Boncompagni, Riccardo ¹, Antonioli, Elisabetta ¹⁸, Carnevale, Fabrizio ¹⁹, Tozzi, Monica ²⁰, Selleri, Carmine ²¹, Fanin, Renato ², Patriarca, Francesca ²

Source: In Transplantation and Cellular Therapy January 2025 31(1):26-26

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

Authors: Bruzzese, Antonella, Derudas, Daniele, Galli, Monica, Martino, Enrica Antonia, Rocco, Stefano, Conticello, Concetta, Califano, Catello, Giuliani, Nicola, Mangiacavalli, Silvia, Farina, Giuliana, Lombardo, Alessandra, Brunori, Marino, Rossi, Elena, Antonioli, Elisabetta, Ria, Roberto, Zambello, Renato, Di Renzo, Nicola, Mele, Giuseppe, Marcacci, Gianpaolo, Pietrantuono, Giuseppe, Palumbo, Gaetano, Cascavilla, Nicola, Cerchione, Claudio, Belotti, Angelo, Criscuolo, Clelia, Uccello, Giuseppina, Curci, Paola, Vigna, Ernesto, Mendicino, Francesco, Iaccino, Enrico, Mimmi, Selena, Botta, Cirino, Vincelli, Donatella, Sgherza, Nicola, Bonalumi, Angela, Cupelli, Luca, Stocchi, Raffaella, Martino, Massimo, Ballanti, Stelvio, Gangemi, Dominella, Gagliardi, Alfredo, Gamberi, Barbara, Pompa, Alessandra, Tripepi, Giovanni, Frigeri, Ferdinando, Consoli, Ugo, Bringhen, Sara, Zamagni, Elena, Patriarca, Francesca, Stefano, Valerio, Di Raimondo, Francesco, Palmieri, Salvatore, Petrucci, Maria Teresa, Offidani, Massimo, Musto, Pellegrino, Boccadoro, Mario, Cavo, Michele, Neri, Antonino, Morabito, Fortunato, Gentile, Massimo

Source: Hematological oncology. 40(4):704-715

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194610175.0x000001&indx=1&recIds=ETOCvdc_100194610175.0x000001

Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro‐prospective observational study

Authors: Del Giudice, Maria Livia, Gozzetti, Alessandro, Antonioli, Elisabetta, Attucci, Irene, Pengue, Ludovica, Cassano Cassano, Raffaella, Ghio, Francesco, Orciuolo, Enrico, Simoncelli, Martina, Bocchia, Monica, Galimberti, Sara, Buda, Gabriele

Source: European journal of haematology. 109(4):373-380

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184995610.0x000001&indx=1&recIds=ETOCvdc_100184995610.0x000001

Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study

Authors: Efficace, Fabio ^*, Gaidano, Gianluca, Petrucci, Maria Teresa, Niscola, Pasquale, Cottone, Francesco, Codeluppi, Katia, Antonioli, Elisabetta, Tafuri, Agostino, Larocca, Alessandra, Potenza, Leonardo, Fozza, Claudio, Pastore, Domenico, Rigolin, Gian Matteo, Offidani, Massimo, Romano, Alessandra, Kyriakou, Charalampia, Cascavilla, Nicola, Gozzetti, Alessandro, Derudas, Daniele, Vignetti, Marco, Cavo, Michele

Source: In The Lancet Healthy Longevity September 2022 3(9):e628-e635

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

Authors: Larocca, Alessandra ^*, Bonello, Francesca, Gaidano, Gianluca, D'Agostino, Mattia, Offidani, Massimo, Cascavilla, Nicola, Capra, Andrea, Benevolo, Giulia, Tosi, Patrizia, Galli, Monica, Marasca, Roberto, Giuliani, Nicola, Bernardini, Annalisa, Antonioli, Elisabetta, Rota-Scalabrini, Delia, Cellini, Claudia, Pompa, Alessandra, Monaco, Federico, Patriarca, Francesca, Caravita di Toritto, Tommaso, Corradini, Paolo, Tacchetti, Paola, Boccadoro, Mario, Bringhen, Sara

Source: In Blood 3 June 2021 137(22):3027-3036

Ventricular tachyarrhythmias and sudden cardiac death in light‐chain amyloidosis: a clash of cardio‐toxicities?

Authors: Zampieri, Mattia, Allinovi, Marco, Olivotto, Iacopo, Antonioli, Elisabetta, Gabriele, Martina, Argirò, Alessia, Fumagalli, Carlo, Nardi, Giulia, Di Mario, Carlo, Vannucchi, Alessandro M., Perfetto, Federico, Cappelli, Francesco

Source: British journal of haematology. 193(4):e27-e31

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100129458760.0x000001&indx=1&recIds=ETOCvdc_100129458760.0x000001

Lenalidomide: A double‐edged sword for concomitant multiple myeloma and post‐essential thrombocythemia myelofibrosis

Authors: Loscocco, Giuseppe G., Antonioli, Elisabetta, Romano, Ilaria, Vergoni, Federica, Rotunno, Giada, Mannelli, Francesco, Guglielmelli, Paola, Vannucchi, Alessandro M.

Source: American journal of hematology. 96(6):749-754

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120465480.0x000001&indx=1&recIds=ETOCvdc_100120465480.0x000001

A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma

Authors: Rocchi, Serena, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Rizzello, Ilaria, di Giovanni Bezzi, Chiara, Scalese, Marco, Dozza, Luca, Marzocchi, Giulia, Martello, Marina, Barilà, Gregorio, Antonioli, Elisabetta, Staderini, Michela, Buda, Gabriele, Petrini, Mario, Cea, Michele, Quaresima, Micol, Furlan, Anna, Bonalumi, Angela, Cavo, Michele, Zamagni, Elena

Source: Hematological oncology. 39(1):41-50

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100115886453.0x000001&indx=1&recIds=ETOCvdc_100115886453.0x000001

Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study

Authors: Rizzello, Ilaria, Cavo, Michele, Dozza, Luca, Rivolti, Elena, Petrucci, Maria Teresa, De Stefano, Valerio, Antonioli, Elisabetta, Tosi, Patrizia, D'Agostino, Mattia, Morè, Sonia, Gozzetti, Alessandro, Cea, Michele, Barbato, Simona, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Rocchi, Serena, De Cicco, Gabriella, Fusco, Alessio, Zamagni, Elena

Source: Leukemia & lymphoma. 62(8):1897-1906

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157633807.0x000001&indx=1&recIds=ETOCvdc_100157633807.0x000001

Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports. (Spanish)

Authors: Attucci, Irene, Pilerci, Sofia, Messeri, Maria, Pengue, Ludovica, Tomasino, Giulia, Caroti, Leonardo, Vannucchi, Alessandro M., Antonioli, Elisabetta

Source: Cancer Reports; Oct2024, Vol. 7 Issue 10, p1-9, 9p

Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience

Authors: Antonioli, Elisabetta, Staderini, Michela, Pilerci, Sofia, Perfetto, Federico, Cappelli, Francesco, Allinovi, Marco, Nozzoli, Chiara, Attucci, Irene, Buzzichelli, Alessandra, Messeri, Maria, Bosi, Alberto

Source: Leukemia & lymphoma. 61(13):3255-3258

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100112956310.0x000001&indx=1&recIds=ETOCvdc_100112956310.0x000001

Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients

Authors: Antonioli, Elisabetta, Nozzoli, Chiara, Buda, Gabriele, Staderini, Michela, Boncompagni, Riccardo, Martini, Francesca, Petrini, Mario, Bosi, Alberto, Saccardi, Riccardo

Source: European journal of haematology. 104(2):138-144

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100149992041.0x000001&indx=1&recIds=ETOCvdc_100149992041.0x000001

Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?

Authors: Martino, Massimo, Gamberi, Barbara, Antonioli, Elisabetta, Aquino, Sara, Della Pepa, Roberta, Malerba, Lara, Mangiacavalli, Silvia, Pezzatti, Sara, Bringhen, Sara, Zamagni, Elena

Source: Expert Review of Hematology; Jul2024, Vol. 17 Issue 7, p375-390, 16p

Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study

Authors: Attardi, Enrico, Pilerci, Sofia, Attucci, Irene, Buzzichelli, Alessandra, Messeri, Maria, Staderini, Michela, Vannucchi, Alessandro M, Antonioli, Elisabetta

Source: Clinical lymphoma, myeloma & leukemia. 21(11):e850-e852

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168424519.0x000001&indx=1&recIds=ETOCvdc_100168424519.0x000001

Belantamab mafodotin in triple‐refractory multiple myeloma patients: A retro‐prospective observational study in Italy.

Authors: Fazio, Francesca, Petrucci, Maria Teresa, Corvatta, Laura, Piciocchi, Alfonso, Pepa, Roberta Della, Tacchetti, Paola, Musso, Maurizio, Zambello, Renato, Belotti, Angelo, Bringhen, Sara, Antonioli, Elisabetta, Conticello, Concetta, Renzo, Nicola Di, De Stefano, Valerio, Musto, Pellegrino, Gamberi, Barbara, Derudas, Daniele, Boccadoro, Mario, Offidani, Massimo, Morè, Sonia

Source: EJHaem; Jun2024, Vol. 5 Issue 3, p485-493, 9p

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Authors: Passamonti, Francesco, Thiele, Jürgen, Girodon, Francois, Rumi, Elisa, Carobbio, Alessandra, Gisslinger, Heinz, Kvasnicka, Hans Michael, Ruggeri, Marco, Randi, Maria Luigia, Gangat, Naseema, Vannucchi, Alessandro Maria, Gianatti, Andrea, Gisslinger, Bettina, Müllauer, Leonhard, Rodeghiero, Francesco, d'Amore, Emanuele S.G., Bertozzi, Irene, Hanson, Curtis A., Boveri, Emanuela, Marino, Filippo, Maffioli, Margherita, Caramazza, Domenica, Antonioli, Elisabetta, Carrai, Valentina, Buxhofer-Ausch, Veronika, Pascutto, Cristiana, Cazzola, Mario, Barbui, Tiziano, Tefferi, Ayalew

Source: In Blood 9 August 2012 120(6):1197-1201

MM-355 Daratumumab + Bortezomib/Lenalidomide/Dexamethasone in (D-VRd) Transplant-Eligible (TE) Patients With Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) in the Phase 3 PERSEUS Study

Authors: Sonneveld, Pieter, Moreau, Philippe, Dimopoulos, Meletios A., Quach, Hang, Ho, P. Joy, Beksac, Meral, Hulin, Cyrille, Antonioli, Elisabetta, Leleu, Xavier, Mangiacavalli, Silvia, Perrot, Aurore, Cavo, Michele, Belotti, Angelo, Broijl, Annemiek, Gay, Francesca, Mina, Roberto, Nijhof, Inger S., van de Donk, Niels W.C.J., Katodritou, Eirini, Schjesvold, Fredrik, Sureda Balari, Anna, Rosiñol, Laura, Cavo, Michel, Roeloffzen, Wilfried, Driessen, Christoph, Vangsted, Annette, Einsele, Hermann, Spencer, Andrew, Hajek, Roman, Jurczyszyn, Artur, Lonergan, Sarah, Liu, Yanfang, Wang, Jianping, Vieyra, Diego, van Brummelen, Emilie M.J., Vanquickelberghe, Veronique, de Boer, Carla J., Carson, Robin, Bladé, Joan, Boccadoro, Mario, Rodriguez-Otero, Paula

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S550-S551

MM-329 Daratumumab + Bortezomib/Lenalidomide/Dexamethasone (D-VRd) in Transplant-Eligible (TE) Patients With Newly Diagnosed Myeloma (NDMM): Analysis of the Phase 3 PERSEUS Study Based on High-Risk Cytogenetic Abnormalities (HRCAs)

Authors: Dimopoulos, Meletios A., Sonneveld, Pieter, Rodriguez-Otero, Paula, Quach, Hang, Ho, P. Joy, Beksac, Meral, Hulin, Cyrille, Antonioli, Elisabetta, Leleu, Xavier, Mangiacavalli, Silvia, Perrot, Aurore, Cavo, Michele, Belotti, Angelo, Broijl, Annemiek, Gay, Francesca, Mina, Roberto, Nijhof, Inger S., van de Donk, Niels W.C.J., Katodritou, Eirini, Schjesvold, Fredrik, Sureda Balari, Anna, Rosiñol, Laura, Cavo, Michel, Roeloffzen, Wilfried, Driessen, Christoph, Vangsted, Annette, Einsele, Hermann, Spencer, Andrew, Hajek, Roman, Jurczyszyn, Artur, Lonergan, Sarah, Liu, Yanfang, Wang, Jianping, Vieyra, Diego, van Brummelen, Emilie M.J., Vanquickelberghe, Veronique, de Boer, Carla J., Carson, Robin, Bladé, Joan, Boccadoro, Mario, Moreau, Philippe

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S547-S548

Daratumumab + Bortezomib/Lenalidomide/Dexamethasone in (D-VRd) Transplant-Eligible (TE) Patients With Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) in the Phase 3 PERSEUS Study

Authors: Sonneveld, Pieter, Moreau, Philippe, Dimopoulos, Meletios A., Quach, Hang, Joy Ho, P., Beksac, Meral, Hulin, Cyrille, Antonioli, Elisabetta, Leleu, Xavier, Mangiacavalli, Silvia, Perrot, Aurore, Cavo, Michele, Belotti, Angelo, Broijl, Annemiek, Gay, Francesca, Mina, Roberto, Nijhof, Inger S., van de Donk, Niels W.C.J., Katodritou, Eirini, Schjesvold, Fredrik, Sureda Balari, Anna, Rosiñol, Laura, Delforge, Michel, Roeloffzen, Wilfried, Driessen, Christoph, Vangsted, Annette, Einsele, Hermann, Spencer, Andrew, Hajek, Roman, Jurczyszyn, Artur, Lonergan, Sarah, Liu, Yanfang, Wang, Jianping, Vieyra, Diego, van Brummelen, Emilie M.J., Vanquickelberghe, Veronique, Sitthi-Amorn, Anna, de Boer, Carla J., Carson, Robin, Bladé, Joan, Boccadoro, Mario, Rodriguez-Otero, Paula

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S236-S236

Daratumumab + Bortezomib/Lenalidomide/Dexamethasone (D-VRd) in Transplant-Eligible (TE) Patients With Newly Diagnosed Myeloma (NDMM): Analysis of the Phase 3 PERSEUS Study Based on High-Risk Cytogenetic Abnormalities (HRCAs)

Authors: Dimopoulos, Meletios A., Sonneveld, Pieter, Rodriguez-Otero, Paula, Quach, Hang, Joy Ho, P., Beksac, Meral, Hulin, Cyrille, Antonioli, Elisabetta, Leleu, Xavier, Mangiacavalli, Silvia, Perrot, Aurore, Cavo, Michele, Belotti, Angelo, Broijl, Annemiek, Gay, Francesca, Mina, Roberto, Nijhof, Inger S., van de Donk, Niels W.C.J., Katodritou, Eirini, Schjesvold, Fredrik, Sureda Balari, Anna, Rosiñol, Laura, Delforge, Michel, Roeloffzen, Wilfried, Driessen, Christoph, Vangsted, Annette, Einsele, Hermann, Spencer, Andrew, Hajek, Roman, Jurczyszyn, Artur, Lonergan, Sarah, Liu, Yanfang, Wang, Jianping, Vieyra, Diego, van Brummelen, Emilie M.J., Vanquickelberghe, Veronique, Sitthi-Amorn, Anna, de Boer, Carla J., Carson, Robin, Bladé, Joan, Boccadoro, Mario, Moreau, Philippe

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S235-S235